Compounds > 5-hydroxytryptophan

5-hydroxytryptophan and levoleucovorin

5-hydroxytryptophan has been researched along with levoleucovorin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butler, IJ; Irons, M; Kaufman, S; Langlais, PJ; Levy, HL; Milstien, S; O'Flynn, ME; Stack, CV1
Lejeune, J; Maunoury, C; Prieur, M; Raoul, O; Réthoré, MO1
Goldstein, DS; Hahn, SH; Harvey-White, J; Holmes, C; Kaufman, S; Milstien, S; Tifft, C1

Other Studies

3 other study(ies) available for 5-hydroxytryptophan and levoleucovorin

ArticleYear
Folinic acid therapy in treatment of dihydropteridine reductase deficiency.
    The Journal of pediatrics, 1987, Volume: 110, Issue:1

    Topics: 5-Hydroxytryptophan; Brain; Carbidopa; Drug Therapy, Combination; Female; Folic Acid; Humans; Infant; Infant, Newborn; Leucovorin; Levodopa; Male; NADH, NADPH Oxidoreductases; Neurotransmitter Agents; Phenylketonurias

1987
[Fragile site Xq27 and metabolism of monocarbons. Significant decrease of the frequency of chromosomal gaps by treatment in vitro and in vivo].
    Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie, 1981, Feb-16, Volume: 292, Issue:7

    Topics: 5-Hydroxytryptophan; Amino Acids; Aminolevulinic Acid; Cells, Cultured; Child; Chromosome Deletion; Female; Humans; Hydroxyproline; Leucovorin; Lymphocytes; Male; Mitosis; Sex Chromosome Aberrations; X Chromosome

1981
Monoaminergic effects of folinic acid, L-DOPA, and 5-hydroxytryptophan in dihydropteridine reductase deficiency.
    Journal of neurochemistry, 1995, Volume: 64, Issue:6

    Topics: 5-Hydroxytryptophan; Biogenic Monoamines; Humans; Infant; Leucovorin; Levodopa; Male; Phenylketonurias

1995